Literature DB >> 6092721

Classification of herpesvirus saimiri into three groups based on extreme variation in a DNA region required for oncogenicity.

P Medveczky, E Szomolanyi, R C Desrosiers, C Mulder.   

Abstract

The leftmost 7 kilobase pairs of unique sequence L-DNA of herpesvirus saimiri was found to be highly variable among different strains as determined by restriction endonuclease analysis and blot hybridization. This region in one group of viruses (group A) showed only very weak hybridization with the DNA of two other groups. Similarly, a fragment of group B hybridized to DNA of its own group much more strongly than to group A. No homology was detected within a 1.2-kilobase-pair region between strain 11 (group A virus) and strain SMHI (group B) even under reduced stringency, and the adjacent 5.5-kilobase-pair segment of the region showed only a very weak intergroup hybridization. DNA of a third group of viruses (non-A, non-B) did not hybridize significantly with cloned fragments representing the leftmost 7-kilobase-pair region of either group A or group B. Since sequences in the highly variable region are required for the oncogenicity of the virus, these results raise interesting questions regarding the origin and function of this region of the genome.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092721      PMCID: PMC254617     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Purification of Herpesvirus saimiri DNA.

Authors:  R Laufs; B Fleckenstein
Journal:  Bibl Haematol       Date:  1973

3.  Spontaneous Herpesvirus saimiri lymphoma in an owl monkey.

Authors:  R D Hunt; F G Garcia; H H Barahona; N W King; C E Fraser; L V Meléndez
Journal:  J Infect Dis       Date:  1973-06       Impact factor: 5.226

4.  Isolation of Herpesvirus saimiri from blood of squirrel monkeys (Saimiri sciureus).

Authors:  L A Falk; L G Wolfe; F Deinhardt
Journal:  J Natl Cancer Inst       Date:  1972-05       Impact factor: 13.506

5.  Herpesvirus saimiri. II. Experimentally induced malignant lymphoma in primates.

Authors:  L V Meléndez; R D Hunt; M D Daniel; F G García; C E Fraser
Journal:  Lab Anim Care       Date:  1969-06

6.  Herpesvirus saimiri: VII. Induction of malignant lymphoma in New Zealand white rabbits.

Authors:  M D Daniel; L V Meléndez; R D Hunt; N W King; M Anver; C E Fraser; H Barahona; R B Baggs
Journal:  J Natl Cancer Inst       Date:  1974-12       Impact factor: 13.506

7.  Susceptibility to Herpesvirus saimiri and antibody development in old and new world monkeys.

Authors:  R Laufs; B Fleckenstein
Journal:  Med Microbiol Immunol       Date:  1973-03-08       Impact factor: 3.402

8.  Repetitive sequences in complete and defective genomes of Herpesvirus saimiri.

Authors:  B Fleckenstein; G W Bornkamm; H Ludwig
Journal:  J Virol       Date:  1975-02       Impact factor: 5.103

9.  Purification and properties of Herpesvirus saimiri DNA.

Authors:  B Fleckenstein; H Wolf
Journal:  Virology       Date:  1974-03       Impact factor: 3.616

10.  An apparently new herpesvirus from primary kidney cultures of the squirrel monkey (Saimiri sciureus).

Authors:  L V Melendez; M D Daniel; R D Hunt; F G Garcia
Journal:  Lab Anim Care       Date:  1968-06
View more
  55 in total

Review 1.  Signaling activities of gammaherpesvirus membrane proteins.

Authors:  B Damania; J K Choi; J U Jung
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations.

Authors:  J C Zong; D M Ciufo; D J Alcendor; X Wan; J Nicholas; P J Browning; P L Rady; S K Tyring; J M Orenstein; C S Rabkin; I J Su; K F Powell; M Croxson; K E Foreman; B J Nickoloff; S Alkan; G S Hayward
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

Review 3.  Evolutionary aspects of oncogenic herpesviruses.

Authors:  J Nicholas
Journal:  Mol Pathol       Date:  2000-10

4.  The collagen repeat sequence is a determinant of the degree of herpesvirus saimiri STP transforming activity.

Authors:  J K Choi; S Ishido; J U Jung
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  In vitro immortalization of marmoset cells with three subgroups of herpesvirus saimiri.

Authors:  E Szomolanyi; P Medveczky; C Mulder
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

6.  Herpesvirus saimiri antagonizes nuclear domain 10-instituted intrinsic immunity via an ORF3-mediated selective degradation of cellular protein Sp100.

Authors:  Florian Full; Nina Reuter; Katrin Zielke; Thomas Stamminger; Armin Ensser
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

7.  Functional phenotype of transformed human alphabeta and gammadelta T cells determined by different subgroup C strains of herpesvirus Saimiri.

Authors:  H Fickenscher; C Bökel; A Knappe; B Biesinger; E Meinl; B Fleischer; B Fleckenstein; B M Bröker
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

8.  Expression of collagenlike sequences by a tumor virus, herpesvirus saimiri.

Authors:  P Geck; S A Whitaker; M M Medveczky; P G Medveczky
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

9.  Genetic variation of herpesvirus saimiri subgroup A transforming protein and its association with cellular src.

Authors:  H Lee; J J Trimble; D W Yoon; D Regier; R C Desrosiers; J U Jung
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

10.  Herpesvirus ateles Tio can replace herpesvirus saimiri StpC and Tip oncoproteins in growth transformation of monkey and human T cells.

Authors:  Jens-Christian Albrecht; Brigitte Biesinger; Ingrid Müller-Fleckenstein; Doris Lengenfelder; Monika Schmidt; Bernhard Fleckenstein; Armin Ensser
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.